SELLAS Life Sciences Group has delivered a very large 3 year return, yet the stock currently screens as expensive on broad ...

SELLAS Life Sciences Group (NasdaqCM:SLS) has amended executive employment and severance agreements tied to a potential change in control. The move comes as the company approaches final analysis of ...

Both Pfizer and Gilead Sciences just flashed the same ominous technical warning while trading below analyst fair value.

The life sciences tools and services sector is back in focus after Merck KGaA (MKGAF) agreed to acquire Bio-Techne (TECH) for $73 per share in cash, valuing the deal at an enterprise value of around ...

Cassava Sciences (SAVA) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The ...

Digital engineering practices improve data accessibility and traceability while preparing life science organizations for ...

The U.S. life sciences industry is showing early signs of a sustained recovery, providing a potential catalyst for one of commercial real estate's most challenged sectors as renewed hiring and venture ...